Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Fiona M Healy

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
British Journal of Pharmacology|February 26, 2021
The importance of Ras in drug resistance in cancerFiona M Healy, Ian A Prior, David J MacEwan
Frontiers in Pharmacology|October 7, 2024
Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?Fiona M Healy, Amy L Turner, Vanessa Marensi, et al.
Journal of Hematology & Oncology|May 19, 2022
Worked to the bone: antibody-based conditioning as the future of transplant biologyJames M Griffin, Fiona M Healy, Lekh N Dahal, et al.
Frontiers in Oncology|November 15, 2021
Recent Progress in Interferon Therapy for Myeloid MalignanciesFiona M Healy, Lekh N Dahal, Jack R E Jones, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
British Journal of Pharmacology|February 26, 2021
The importance of Ras in drug resistance in cancerFiona M Healy, Ian A Prior, David J MacEwan
Frontiers in Pharmacology|October 7, 2024
Mediating kinase activity in Ras-mutant cancer: potential for an individualised approach?Fiona M Healy, Amy L Turner, Vanessa Marensi, et al.
Journal of Hematology & Oncology|May 19, 2022
Worked to the bone: antibody-based conditioning as the future of transplant biologyJames M Griffin, Fiona M Healy, Lekh N Dahal, et al.
Frontiers in Oncology|November 15, 2021
Recent Progress in Interferon Therapy for Myeloid MalignanciesFiona M Healy, Lekh N Dahal, Jack R E Jones, et al.
Pageof 1